Functional assays confirmed that MMP9 knockdown increased anoikis by 59% and significantly reduced wound-healing migration by about 30% and transwell invasion by 50%, reinforcing its role in RCC progression. This evidence concerns the gene MMP9 and renal cell carcinoma.